Linsidomine hydrochloride
- Level
- Commodity
- Parent
- 51412000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51412014This classification denotes a vasodilating agent and nitric oxide-releasing compound with the molecular formula C6H10N4O2.CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y0054U597M. European Medicines Agency schedules linsidomine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB21667. The term linsidomine hydrochloride is a U.S. FDA designation. Most nations, for tariff and trade purposes, schedule linsidomine hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, LINSIDOMINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: C1C(ON[N+]1N2CCOCC2)N.[CL-].
Same parent
Under 51412000 · 15Activities that produce or sell this
KBLI · 8Inherited from family 51410000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.